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ABSTRACT 
 
Molecular Studies in Horses with SRY-positive XY Sex Reversal Syndrome.  
(December 2011)  
Erica Fang, B.S., Texas A&M University  
Co-Chairs of Advisory Committee, Dr. Terje Raudsepp 
                   Dr. Bhanu Chowdhary 
 
 Sex determination in mammals is regulated by the sex-determining region on the 
Y chromosome (SRY); the presence of SRY activates the male developmental pathway 
and suppresses the gene network necessary for female gonad development.  Mutations in 
sex determination genes lead to various abnormal sexual phenotypes, including sex 
reversal syndrome in which the genetic and phenotypic sex do not match.  Sex reversal 
syndrome has been reported in humans, mouse, and several domestic species.  In horses, 
SRY-negative XY sex reversal syndrome has been well described and is caused by 
deletions on the Y chromosome.  However, the molecular causes of the SRY-positive 
condition in horses and other mammals are not known.   
 This research investigated five horses affected with SRY-positive XY sex reversal 
syndrome.  Sequencing of the coding exon region of the SRY gene in the five cases 
showed 99-100% alignment with the sequences of normal males.  Genotyping of two 
closely related individuals with 46 normal male controls on an equine SNP50 Beadchip 
identified two statistically significant SNPs in a ~16 Mb region on the long arm of horse 
chromosome 3 (ECA3q).  The region was analyzed using Gene Ontology (GO) and 
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Gene Relationships Across Implicated Loci (GRAIL) to select functionally relevant 
candidate genes for sequencing.  Further analysis of the entire horse genome was done 
through array comparative genomic hybridization (aCGH), which investigated possible 
structural rearrangements, such as copy number variants (CNVs).  Deletions of olfactory 
receptor genes were detected on multiple chromosomes and confirmed through 
quantitative real-time PCR (qPCR).  A homozygous deletion on ECA29 in a region 
containing genes of the aldo-keto reductase gene family, known to play a role in 
interconverting sex hormones between active forms and inactive forms, was discovered 
in two sex reversed animals.  The findings were confirmed through qPCR and 
fluorescence in situ hybridization (FISH), and experiments to define the specific 
breakpoints of the deletion through PCR have been initiated. 
 This research represents the first systematic search in the horse genome for 
mutations and CNVs related to sex determination.  The findings contribute to better 
understanding of the molecular mechanisms of sex determination in horses and other 
mammals, including humans. 
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NOMENCLATURE 
 
aCGH Array comparative genomic hybridization  
AIS Androgen insensitivity syndrome 
AKR1CL1 Aldo-keto reductase family 1, member C-like 1 
AR Androgen receptor 
BAC Bacterial Artificial Chromosome  
bp base-pair  
BIO Biotin  
Cbln4 Cerebellin 4 precursor  
CBX2 Chromobox homolog 2 
CNV Copy Number Variation  
CNVR Copy number variation region 
CSMD1 CUB and Sushi multiple domains 1 
DAX1 Dosage sensitive sex-reversal  
DIG Digoxigenin  
DLRSD Derivative log ratio standard deviation 
DMRT1 Double sex and mab-3 related transcription factor 1 
Fgf9 Fibroblast growth factor 9 
FISH Fluorescence in situ Hybridization  
GATA4 GATA binding protein 4 
GO Gene ontology  
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GRAIL Gene relationships across implicated loci  
HMG High-mobility group  
IBD Identity-by-descent  
kb kilobase-pair  
Mb Megabase-pair  
MHC Major histocompatibility complex 
MNS1 Meiosis-specific nuclear structural 1 
NIPAL1 NIPA-like domain containing 1 
PAR Pseudoautosomal region 
PCR Polymerase chain reaction  
qPCR Quantitative real-time PCR  
Sf1 Steroidogenic factor 1 
SNP Single nucleotide polymorphism 
SOX9 SRY-box 9 protein 
SRY Sex determining region on the Y chromosome 
TDF Testis-determining factor 
TEX9 Testis expressed 9 
WNT4 Wingless type MMTV integration site family, member 4 
Wt1 Wilms’ tumour suppressor gene 1 
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INTRODUCTION 
 
Sex Determination and Sex Chromosomes 
 The mechanism that determines whether an individual is a male, female, or in 
some cases, a hermaphrodite, has been a topic of interest for centuries.  Environmental 
theories were prevalent in ancient days; for example, in 335 B.C.E., Aristotle proposed 
that if the heat from the male partner overwhelmed the coldness of the female partner, 
the child would develop as a male.  As science progressed, the invention of the 
microscope and other scientific tools revolutionized many biological fields, including 
genetics.  In 1891, German biologist Hermann Henking observed a difference in 
chromosome numbers while studying sperm in wasps (Pyrrhocoris apterus): some had 
11 chromosomes, and others had 12.  Noticing that the additional twelfth chromosome 
looked different from the others, he named this mysterious chromosome the “X element” 
and hypothesized that it played some role in sex determination in insects (Henking 
1891).  About a decade later, American zoologist C. E. McClung showed that the “X 
element” or “accessory chromosome” was present only in half of the cells and proposed 
that it might influence sexual determination (McClung 1902). 
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 Around the same time, one of McClung’s former students, Walter Sutton, was 
studying meiosis in sperm cells in grasshoppers.  Counting and measuring the size of 
each chromosome led him to conclude that gametes carry half of the genetic material in 
a zygote and that the merging of two gametes during fertilization forms chromosome 
pairs (Sutton 1902).  Sutton’s work set the basis for the chromosome theory of 
inheritance. 
 Shortly after Sutton published his work, sex chromosomes were discovered by 
American researchers Nettie Stevens and Edmund Beecher Wilson, who noted 
differences in chromosome patterns between male and female beetles (Tenebrio molitor)   
(Stevens 1905; Wilson 1905). Wilson noticed that one chromosome pair in the males 
was mismatched and assumed the larger chromosome was the “X element” or the 
“accessory chromosome” known today as the “X chromosome”, while the smaller, 
crumpled partner was subsequently named the “Y chromosome”.  His later work 
established chromosomal sex determination systems XX/XO and XX/XY where 
maleness was determined either by the lack of one X chromosome or the presence of the 
Y chromosome, respectively (Wilson 1905).   
Additional analyses of sex chromosomes in other species over the next couple of 
decades revealed diversity in sex determination systems.  Species of insects, reptiles and 
amphibians align with Aristotle’s environmental hypothesis and are temperature 
dependent for sex determination; for example, in a certain species of moths (Talaeporia 
tubulosa), ambient temperature controls sex determination (Traut et al. 2007).  The 
haplodiploidy sex determination system distinguishes the sex of insects such as 
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honeybees and wasps (van Wilgenburg et al. 2006).  Many insects and nematodes utilize 
the XX/XO system in which the male has only one sex chromosome, as was seen in 
McClung’s and Sutton’s works.  Research in birds, snakes, fish, and butterflies has 
revealed a ZZ/ZW system where females are heterogametic (ZW) and males are 
homogametic (ZZ) (Clinton 1998).  Some extreme sex determination systems have 
multiple X and Y chromosomes or multiple Z and W chromosomes, for example, the 
X1-X5/Y1-Y5 system observed in monotremes (Watson 1990).  Most mammals, 
including humans, have the XX/XY sex chromosome system where males are 
heterogametic (XY) and females are homogametic (XX) (Tijo & Levan 1956).  There 
are exceptions in mammals, such as the Ryukyu spiny rats (genus Tokudaia) and several 
members of the genus Microtidae, in which the males lack a Y chromosome or the 
females and males have the same karyotype (Marchal et al. 2003), but generally, the 
XX/XY system in mammals differentiates females and males genetically.  
 
Mammalian Sex Chromosomes 
 The mammalian X and Y chromosomes are thought to have evolved from a pair 
of identical autosomes after one chromosome acquired an allelic variation beneficial to 
males (Muller 1914; Lahn & Page 1999).  As the Y chromosome gained other genes 
beneficial to males, recombination between the two chromosome pairs became 
increasingly suppressed, and the Y chromosome gradually degenerated in size and gene 
content (Lahn & Page 1999).  As a result, the two chromosomes diverged in sequence 
homology except for the pseudoautosomal region (PAR), which allows the two 
  
4 
chromosomes to pair during male meiosis (Burgoyne 1982; Freije et al. 1992).  In 
contrast to the smaller Y chromosome, the X chromosome is larger, represents 
approximately 5% of the genome, contains about 1000 genes, and is evolutionarily well-
conserved across mammalian species (Ross et al. 2005).  Due to its degeneration, small 
size, and low gene content, the Y chromosome was thought to be degenerate and on the 
road to extinction.  However, the completion of the human (Skaletsky et al. 2003) and 
chimp (Hughes et al. 2010) Y chromosome sequencing and the Y chromosome studies 
in other mammalian species, such as cats (Murphy et al. 1999), cattle (Liu et al. 2002), 
and horses (Raudsepp et al. 2004; Paria et al. 2011) refuted these ideas, providing a 
clearer understanding of the structure and organization of this underestimated sex 
chromosome.  The mammalian Y chromosome, though small and gene-poor compared 
to the autosomes and the X chromosome, contains a number of genes, several of which 
are involved in spermatogenesis, male fertility, and sex determination (Rozen et al. 
2003). 
 
Sex Determining Region on the Y Chromosome (SRY) 
 In the 1950s, human studies in females with Turner syndrome (45,XO) and males 
with Klinefelter’s syndrome (47,XXY) established that the Y chromosome determined 
maleness (Jacobs & Strong 1959).  The search for the testis-determining factor (TDF in 
human or Tdy in mouse) on the Y chromosome lasted for several decades with numerous 
candidate genes being studied and discounted (Silvers et al. 1977; Page et al. 1987) until 
the early 1990s when the sex determining region on the Y chromosome (SRY) was 
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identified as the necessary and sufficient locus for male sex determination (Gubbay et al. 
1990; Sinclair et al. 1990; Koopman et al. 1991).  Experiments in transgenic mice 
proved that SRY acts as the dominant male determinant gene.  The expression of SRY in 
the early embryo triggers and coordinates testes formation from the bipotential gonad 
and effectively suppresses the genes involved in the female developmental pathway 
(Gubbay et al. 1990).  Subsequent research on the SRY identified several other genes 
involved in mammalian sex determination, including SRY-box 9 protein (SOX9) (Morais 
da Silva et al. 1996), steroidogenic factor (Sf1) (Parker et al. 2002), fibroblast growth 
factor (Fgf9) (Schmahl et al. 2004), and many others (Sekido & Lovell-Badge 2008; 
Marshall Graves 2008).  Despite these achievements, the overall knowledge about the 
complex genetic mechanisms underlying sex determination and sexual differentiation 
beyond the role of SRY in mammals is limited due to many contributing genes and 
pathways.  Consequently, very little is known about the underlying genetics and 
molecular mechanisms of abnormal sexual development, including sex reversal 
syndrome. 
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Genetic Regulation of Sex Determination 
 The SRY gene is directly related to the production of testes in mammals.  
Initially, the genital ridge in the embryo has the potential to develop into either ovaries 
or testes (Fig. 1).  The pathway for the development of testes is determined by the 
activation of the transiently expressed SRY gene and effective down-regulation of genes 
that regulate the ovarian pathway, specifically β-catenin (Wilhelm 2007; Sekido & 
Lovell-Badge 2008; Marshall Graves 2008).  Regulation of the SRY gene is controlled 
by factors such as Wilms’ tumour suppressor gene 1 (Wt1) and Sf1; mutations in these 
regulatory factors lead to a decrease in testis markers, gonad degeneration, and 
decreased SRY expression (Luo et al. 1994; Hammes et al. 2001).  The normal 
expression of SRY triggers the activity of SOX9, another SRY-box containing gene, 
which indispensably regulates the differentiation of the pre-Sertoli cells that lead to the 
production of testes (Kent et al. 1996).  Once SOX9, is up-regulated, SRY is down-
regulated, and the up-regulation of SOX9 is maintained by several genes including Sf1 
(Sekido & Lovell-Badge 2008).  Interestingly, while SRY and SOX9 were discovered to 
be the “master” genes in mammalian male sex determination nearly two decades ago, 
their direct target gene, cerebellin 4 precursor (Cbln4), was identified only recently in 
mouse (Bradford et al. 2009). 
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Figure 1. Mammalian gonad differentiation pathway.  The bipotential gonad can 
differentiate into testis when SRY is present at the correct time and dosage.  When SRY is 
not present, genes in the ovary pathway promote female development (Marshall Graves 
2008). 
 
 
 
 
 
  
8 
High-mobility group (HMG) domains allow the SRY protein to bind and bend 
DNA after it has been transported from the cytoplasm into the nucleus, a dosage-
dependent step critical for the activation of the testes-developing pathway (Kaur et al. 
2010; Ross et al. 2008).  The HMG box is the most conserved region of the SRY gene, 
but the regulation of the remaining SRY coding region and 5’ sequences has been 
difficult to study due to the lack of conservation between species (Ross et al. 2008).  A 
study done by Ross et al. (2008) used comparative genomic analysis of 5’ sequences in 
human, bull, pig, goat, and mouse SRY to identify candidate regulatory regions that are 
homologous amongs those species and potential candidate regions to study sex reversal 
syndrome.  Previous data show the presence of ten highly conserved DNA elements 
from the 5’ region of the SRY gene in ten different mammalian species (Margarit et al. 
1998).  The regulation of transcription factors is crucial for the regulation of SRY 
expression to initiate the cascade of genes that control testes development. 
 
Abnormal Sex Determination – Sex Reversal 
 Disruption of the early steps involving the bipotential gonad can result in 
abnormal gonadal development in both sexes.  Mutations in factors that regulate SRY 
and SOX9, such as Sf1 and Wt1 have been linked to disorders, such as gonadal 
dysgenesis and sex reversal (Fleming and Vilain 2005; Lin et al. 2007).  Sex reversal 
syndrome is a developmental disorder in which there is a discrepancy between the 
phenotypic and genetic sex.  Both male-to-female and female-to-male sex reversal cases 
have been reported and studied in several species, such as mouse (Koopman et al. 1991), 
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human (German et al. 1978; Barbaro et al. 2007; Michala et al. 2008; Biason-Lauber et 
al. 2009; Hersmus et al. 2009), cattle (Ferrer et al. 2009), and horse (Kent et al. 1986).  
Female-to-male XX sex reversed humans are phenotypic males with a fragment of the Y 
chromosome in their genome, generally arising from an illegitimate recombination 
between the X chromosome and Y chromosome during meiosis where the SRY gene is 
translocated onto the X chromosome (de la Chapelle et al. 1984).  Male-to-female XY 
individuals were first described in 1955 by G.I. Swyer; the condition, thus named Swyer 
syndrome, describes individuals who are phenotypically female, but the SRY on their Y 
chromosome may be mutated or deleted, although the majority of reported cases have a 
normal SRY gene (Swyer 1955).  In humans, 10-20% of XY women are SRY-negative, 
and 80-90% have a normal SRY (Sarafoglou & Ostrer 2000; Michala et al. 2008).  The 
molecular causes of this condition may be due to changes on the Y chromosome or other 
regions of the genome; the molecular heterogeneity of XY sex reversal make it difficult 
to pinpoint one cause. 
 Extensive studies in mice have shown that misexpression of SRY due to delayed 
onset or insufficient levels leads to partial or full sex reversal (Albrecht & Eicher 1997, 
Albrecht et al. 2003).  Another study in mice showed that ablation of M33, which is 
involved in the regulation of Sf1 and subsequently SRY, caused male-to-female sex 
reversal (Katoh et al. 1998).  In recent years, extensive genome-wide molecular studies 
of sex reversal have been done in humans using Single Nucleotide Polymorphism (SNP) 
genotyping and Array Comparative Genomic Hybridizations (aCGH).  Loss-of-function 
mutations have been found in the human orthologue of M33, chromobox homolog 2 
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(CBX2) (Biason-Lauber et al. 2009).  A mutation in the human SRY gene, W70L, led to 
decreased SOX9 expression, and therefore a lack of proper testis-determination 
coordination in development (Hersmus et al. 2009).  Further studies in humans have also 
shown that gene dosage plays a critical role in sex determination; duplications of dosage 
sensitive sex-reversal (DAX1) on the X chromosome in humans result in XY individuals 
developing as females (Swain et al. 1998).  Similarly, changes in autosomes can result in 
XY sex reversal.  For example, the short arm of human chromosome 9 (HSA9p) 
contains genes related to gonadal development, and distal deletions in this region have 
been reported in 46,XY sex reversed patients (Barbaro et al. 2009).  In order to examine 
the genome as a whole using a high-throughput method, other recent studies have 
utilized aCGH to examine copy number variations (CNVs) at a high resolution in 46,XY 
sex reversed patients.  CNVs are structural rearrangements in the genome due to 
insertions, deletions, and duplications that result in a change in the effective DNA copy 
number.  Recently, genome-wide aCGH analysis revealed structural changes in three 
regions that likely cause gonadal dysgenesis (White et al. 2011).  These regions involve 
genes previously implicated in sex determination, DAX1 and SOX9, as well as a deletion 
downstream of GATA4, which suggests the involvement of non-coding sequences in 
abnormal sexual development.   
Taken together, molecular causes of XY sex reversal in humans are variable and 
involve single gene mutations, gene copy number variations, or other structural 
rearrangements.  While relatively more information is available for male-to-female XY 
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sex reversal in mouse and human, little is known about the genetics of this condition in 
other species. 
 
Sex Reversal in Horses 
 Sex reversal syndrome is of great concern in the horse (Equus caballus) because 
it affects mare and stallion fertility, an economically valuable trait in the equine industry.  
Additionally, male-to-female sex reversal among high-performance horses, such as 
trotters (http://www.nytimes.com/2009/09/19/sports/19racing.html; 
http://www.thehorse.com/ViewArticle.aspx?ID=14677), might give the carriers an 
advantage over normal females and result in disqualification.   
Both female-to-male and male-to-female sex reversal conditions have been 
reported in several horse breeds (Milliken et al. 1995; Kent et al. 1986).  Male-to-female 
XY sex reversal is the second most frequent sex chromosome abnormality after X 
chromosome monosomy; incidence of XY mares in cytogenetic analysis practice at 
Texas A&M University is as high as 26% among all chromosomally abnormal animals 
studied between 2001 to 2009.  This is consistent with previous data showing that 12-
30% of cytogenetic abnormalities in horses account for XY females (Bowling et al. 
1987; Power 1990; Lear and Bailey 2008; Raudsepp et al. 2010) that are described as 
mares with the karyotype of a stallion (64,XY).  Phenotypes of such animals range from 
feminine to highly-masculinized mares.  The “feminine”-type animals have normal 
female external and internal genitalia and no somatic or behavioral abnormalities (Kent 
et al. 1986; Power 1986; Bowling et al. 1987).  The “masculine”-type animals are often 
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categorized as male pseudohermaphrodites, showing stallion behavior and having 
abnormal genital tracts and gonads (Kent et al. 1986; Bowling et al. 1987; Kent et al. 
1988; Howden 2004; Villagomez et al. 2009; Raudsepp et al. 2010).  All cases thus far 
have been infertile except one that produced a normal 64,XX filly (Sharp et al. 1980).  
Furthermore, cases of both SRY-negative and SRY-positive have been reported in horses. 
The horse SRY is a single copy intron-less SRY gene, which produces a 1,403 
base-pair (bp) linear transcript (Hasegawa et al. 1999).  The majority of mares with a 
stallion karyotype (64,XY) are SRY-negative due to various deletions on the Y 
chromosome.  The deletions can range from 21 kilobase-pairs (kb) to a complete loss of 
the euchromatic region (Raudsepp et al. 2010).  In contrast, the genetic causes of the 
SRY-positive condition remain elusive with only one previous report (Switonski et al. 
2005). 
  
Goals of This Study 
This study builds upon the findings in humans showing that SRY-positive XY sex 
reversal is molecularly heterogeneous (German et al. 1978; Bernstein et al. 1980; 
Vaiman & Pailhoux 2000) and can be associated with both small (SNPs) (Kim et al. 
2010) and large (CNVs) genomic variants (Tannour-Louet et al. 2010; White et al. 
2011).  These changes can affect sex determination genes on the sex chromosomes (e.g. 
SRY, DAX1) or autosomes (e.g. SOX9).  In this study, we used a variety of genomic 
approaches to identify gene mutations and large-scale genomic rearrangements possibly 
associated with XY sex reversal in horses.  The goal of the study was to identify putative 
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causes of sex reversal and facilitate the design of molecular tests for diagnostics and will 
contribute to better understanding of the mechanisms underlying sex determination and 
sexual development in horses and other mammals. 
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MATERIALS AND METHODS 
 
Animals 
This study involved five SRY-positive XY sex reversed mares referred to the 
Texas A&M University Molecular Cytogenetic Laboratory for cytogenetic testing due to 
their infertility and/or abnormal genitalia (Table 1). 
 
Table 1. Summary of SRY-positive XY sex reversed females.  Phenotypes of these 
affected horses are variable and cover a broad spectrum from “feminine”-type animals to 
“masculine”-type animals.  Male pseudohermaphrodites are classified by abnormal 
genital tract development and gonads ranging from ovotestes to testicular feminization. 
 
Animal Breed Phenotype Karyotype PCR with 
SRY 
H169 Appaloosa Normal external genitalia, 
hypoplastic uterus, 
underdeveloped mammary 
glands. Shows estrous 
behavior to stallions. 
64,XY Positive 
H252 Mixed 
warmblood 
Abnormal: uterus, vulva 
located ventrally between rear 
legs at the location of 
mammary glands. 
64,XY Positive 
H348 Standardbred Male pseudohermaphrodite. 64,XY Positive 
H369 Standardbred Male pseudohermaphrodite. 64,XY Positive 
H423 Quarter Horse Male pseudohermaphrodite 
with two testicles. 
64,XY Positive 
 
 
 
DNA Isolation from Peripheral Blood 
Peripheral blood from the cases was collected in sodium heparin and EDTA 
Vacutainers (VACUTAINERTM; Becton Dickinson, Franklin Lakes, NJ, USA).  
Genomic DNA was isolated from the peripheral blood lymphocytes by chloroform-
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phenol extraction (Birren et al. 1997).  Briefly, an equal volume of 2X sucrose/Triton X-
100 (pH 7.6) (Omnipur, EMD Chemicals, Gibbstown, NJ, USA) lysis buffer was 
added to the peripheral blood samples to lyse the red blood cells and platelets.  After a 
20-minute incubation on ice, the cells were centrifuged at 2000 rpm for 20 minutes, and 
the supernatant was discarded.  The pellet was re-suspended in 2X Sucrose/Triton X-100 
with a 5-minute incubation on ice.  The cells were centrifuged again at 2000 rpm for 20 
minutes, and the supernatant discarded.  The pellet was re-suspended in saline EDTA, 
made by dissolving 4.38 g of NaCl and 8.93 g of EDTA (disodium) in 1000 mL of Milli-
Q water and with pH adjusted to 8.0 with 10 N NaOH, to lyse the nucleated white blood 
cells containing the DNA.  Next, 1 mg of Proteinase K (Thermo Fisher Scientific, Inc., 
Waltham, MA, USA) and 250 µL of 20% SDS were was added to digest proteins in the 
cell and dissolve the cell membranes, respectively.  Following an overnight incubation at 
37ºC, an equal volume of phenol:chloroform:isoamyl alcohol (PCI; Roche Diagnostics, 
Mannheim, Germany) was added to separate the DNA from the carbohydrates and 
proteins.  After centrifuging at 13,000 rpm for 5 minutes, the upper aqueous layer 
containing the DNA was transferred into a fresh tube, and the PCI extraction was 
repeated.  The upper aqueous layer was mixed with an equal volume of 
chloroform:isoamyl alcohol (AMRESCO Inc., Solon, OH, USA) and centrifuged at 
13,000 rpm for 5 minutes to remove all traces of phenol.  The final aqueous layer was 
transferred to a fresh tube, and the DNA was precipitated with 2.5 volumes of ice cold 
100% ethanol and 0.1 volumes of 5 M. NaCl.  After incubating at room temperature for 
15 minutes, the samples were centrifuged at 13,000 rpm for 10 minutes, and the 
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supernatant was removed.  The pellets were washed in 70% ethanol, centrifuged at 
13,000 rpm, air-dried, and re-suspended in ddH2O.  Quality of the DNA was checked on 
a Nanodrop spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA, USA) 
and by electrophoresis on an 1% agarose gel. 
 
Chromosome Preparations and Karyotyping 
Chromosome preparations for the five horses were obtained from short-term 
peripheral blood lymphocyte cultures using standard procedures (Raudsepp & 
Chowdhary 2008).  Briefly, peripheral blood was collected in sodium-heparin vacutainer 
tubes, and 1 mL of plasma with buffy coat was added to 9 mL of prewarmed (37°C) cell 
culture media containing RPMI Medium 1640 with Glutamax and 25 mM. HEPES 
buffer (Gibco, Invitrogen, Gaithersburg, MD, USA), 30% fetal bovine serum (GEMINI 
BioProducts, West Sacramento, CA, USA), 1.4% antiobiotic-antimycotic solution 
(Gibco BRL, Life Technologies, Carlsbad, CA, USA), and 1% mitogen (pokeweed: 
lectin from Phytolacca americana, Sigma-Aldrich, St. Louis, MO, USA).  The blood 
and cell culture media were mixed and incubated for 72 hours at 37°C.  One hour before 
harvest, 100 µL of ethidium bromide (1 mg/mL) (Bio-Rad, Hercules, CA, USA) and 100 
µL of demecolcine solution in Hanks’ balanced salt solution (HBSS; 10 µg/mL) (Sigma-
Aldrich, St. Louis, MO, USA) were added and incubated at 37°C.  For the harvest, the 
tubes were centrifuged at 1000 rpm for 10 minutes, and the supernatant was aspirated 
leaving about 1 mL of medium at the bottom.  The cells were re-suspended, mixed with 
prewarmed (37°C) hypotonic solution (0.075 M. KCl) (Rainbow Scientific, Windsor, 
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CT, USA) to a final volume of 10 mL, and then incubated for 30 minutes at 37°C.  The 
tubes were centrifuged at 1000 rpm for 10 minutes, the supernatant was removed, and 
the cells were re-suspended in 5 mL of fresh fixative (methanol/glacial acetic acid in a 
ratio of 3:1) and centrifuged at 1000 rpm for 10 minutes.  The fixative step was repeated 
three times, and after the last treatment, the supernatant was removed leaving about 200 
µL of cells in the fixative, and 10 µL of the fixed suspension was spread on clean slides. 
For karyotyping, the slides were stained with 5% Giemsa in Sørensen phosphate 
buffer (pH 6.8).  The sex chromosomes were identified by C-banding (Arrighi & Hsu 
1971) by treating the slides with 0.2 N HCl for 3 minutes, in 2.5% Ba(OH)2 at 60ºC for 3 
minutes, in 2X SSC at 60ºC for 5 minutes, followed by staining in 5% Giemsa solution 
for 1 hour.  Microscopy was carried out using a Zeiss Axioplan2 fluorescent microscope 
equipped with karyotyping software Ikaros v5.2 (Metasystems GmbH, Altlussheim, 
Germany). 
 
Polymerase Chain Reaction (PCR) with SRY Primers 
The presence of the SRY gene was tested by PCR amplification of genomic DNA 
from each case with the following primers: SRY5.F 5’- TGC ATT CAT GGT GTG GTC 
TC-3’ and SRY5.R 5’-GAA GCC GAA AAA TTG CCA T-3’ (Raudsepp et al. 2010).  
The 10 µL PCR reactions contained 0.25 unit Taq polymerase (JumpStart RedTaq, 
Sigma-Aldrich), 50 mM KCl, 10 mM Tris-HCl (pH 8.4), 0.2 mM dATP, dCTP, dTTP, 
and dGTP, 0.3 µM of each primer, and 50 ng of genomic DNA as a template.  The DNA 
was denatured at 95°C for 30 seconds, annealed at 60°C for 30 seconds, extended at 
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72°C seconds, followed by amplification for 30 cycles using the following program: 
94°C for 30 seconds, 58°C for 30 seconds, 72°C for 30 seconds.  The final extension 
was at 72°C for 10 minutes.  The PCR products were resolved on 2% agarose gels 
containing ethidium bromide. 
 
Sequencing 
Primers were designed for four overlapping fragments in a 1,955 bp region 
containing the SRY exon using Primer 3 v0.4.0 software (Rozen & Skaletsky 2000) 
(Table 2, Fig. 2).  The four fragments were amplified by PCR in all five SRY-positive 
XY sex reversed females and a normal male Thoroughbred (Bravo – the DNA donor of 
the horse genomic bacterial artificial chromosome (BAC) library CHORI-241); the 
DNA was denatured at 95°C for 30 seconds, annealed at 60°C for 30 seconds, extended 
at 72°C seconds, and then amplified for 40 cycles using the following program: 94°C for 
30 seconds, 58°C for 30 seconds, 72°C for 2 minutes.  The final extension was at 72°C 
for 10 minutes.  The PCR products were purified in QIAquick Spin columns (QIAGEN, 
Valencia, CA, USA) and subjected for direct sequencing using BigDye chemistry 
(Applied Biosystems, Carlsbad, CA, USA).  Briefly, a 10 µL sequencing reaction 
contained 2 µL Big Dye (Applied Biosystems, Carlsbad, CA, USA), 2 µL Half Big Dye 
(Applied Biosystems), 1 µL of 20 µM forward or reverse primer, and the template DNA 
(6 ng/100 bp).  The initial denaturation was at 94°C for 3 minutes, followed by a 
sequencing program of 50 cycles: 95°C for 30 seconds, 50°C for 20 seconds, 60°C for 4 
minutes.  The final extension was at 60°C for 10 minutes.  The samples were cleaned in 
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Sephadex Spin-50 mini columns (BIOMAX Inc., Rockville, MD, USA) at 3,600 rpm for 
3 minutes, dried in a vacuum centrifuge (Eppendorf AG, Hamburg, Germany) at 45°C 
and re-suspended in formamide.  Sequencing reactions were resolved on an ABI-3730 
capillary sequencer.  The sequences were aligned with each other and the reference 
sequence (GenBank AC215855.2) using Sequencher v4.7 (Gene Codes) software. 
 
Table 2. Primer sequences for SRY exon sequencing. 
 
 Forward Primer 5’-3’ Reverse Primer 5’-3’ Product Size (bp) 
Fragment 
1 
CGT TTG TGT TTG 
TTA ACG GCT A 
ATC ACG AGA CCA 
CAC CAT GA 
681 
Fragment 
2 
GCA ATC CTG GCT 
CAC ATTT T 
CCT GTT CGG CTC 
TAT TTT CGT 
660 
Fragment 
3 
AAC AGG AGC GTC 
ACA GCA G 
CGC AAG GTA GCT 
GAA AGA CC 
510 
Fragment 
4 
GTT GCG TTT TGA 
TGG GAA AC 
GGG TGT CCC ACT 
CCC ATA AT 
468 
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CGTTTGTGTTTGTTAACGGCTAATAGAATTAGGTCATCTGTAGGCTCTGTGGTTTTAAGATCACACTCACATATATTCA
TATTGATAAAACAATTCATTAGTATCCGTCTGTGCTCCACCTGCATCCTTTCATTTATAGACCTAATAAAATAATAATG
ACAAAGTTTGTTTTGTATTATTTTAAGGAGGGGCAGAGCCTTCAGCGCTGGGGATTAGAAGTAGGGCACAGAAACAGTG
TGTTATTACTCTGTTATCAGGTTTTGCTTGAGAGTGGATAGGCTGGTTGGGCTTTGGCTGACGGCCCAGGACACGTTTG
AGGGGAGGAGTTGGGGGCGGAGAAATAAGTATTTTATTACAAAAGTTGTAGTAACAAAGCCTCTGCTAGAATAACC
TTGGAAAAGTAAGATAATTTTCCCAACGCTTTATCTTCGCATTTTGCTACCACCCTCCTCTTCA
ACGGTGCCATCTTAAGCTTCTGCTATGTCCAGAGTATCCAACAGCGATAATTACAGTCTAGCAG
GACAGCAACATACCGTTCTCGGCTCTGGGAGAACCTCATCCCTACTTTGGACGAGCAATCCTGG
CTCACATTTTCGGAGTGAAACAAGAGGAAATGGTAGAGAGAACGGCCAGGACCGTGTCAAACGA
CCCATGAATGCATTCATGGTGTGGTCTCGTGATCACAGGCGCAAGGTCGCTCTAGAGAATCCCC
AACTGCAAAACTCAGAGATCAGCAAGCGGCTGGGATGCCAGTGGAAAATGCTTACGGAAGCCGA
AAAATTGCCATTCTTCGAGGAGGCACAGAGACTACGGGCTATGCATCAAGAGAAATACCCGGAC
TATAAATATCGACCTCGTCGGAAGGCCAAGATGCCACAGAAAAGTGACAAACCGCTTCCCGCAG
ACTCCTCTTCTACACTGTGCGGGCAGGCGCACGTACACGTCGACGAGTGGTTGAACCCTTTCAC
ATTCACGGACGACTGTACTGAGGCCACACAGTCACAAACGGAGGAGCGGTTAAACCATTCGCAG
CCCGCGAACACAGCTAATTCGGCGCTGCAACAGGAGCGTCACAGCAGCACCGCAACCCTGCGTG
ACAATCGGGTAACGTTGGCTACGCAGACATACGCAGACGTTCCCTTTCACTGTAATTTACCCTC
CGGACTTTCTCACGGTGATTTTCCTTGATTTCCTTACTGGTGGCGGCAGAGTCCCTGTTCGGCT
CTATTTTCGTATTTCTTCTGGAGCCCCAGCGTATCAACACCAGTGAAATTTTGAGTTCCAAGGT
CAGCTGTTTTTCTGTTAATGGAACAGTTTGTAATCTAATTTTAGTCTTCCAGAGGTTGTCCTTT
AAATAGCGCTAAGCATATATTGATACACTAATAATCGCCAGCATAGATCACAGAATTCTAACTCT
TTATTTTAAATACTATAAGTCACAAACATAGTGGAGAGAAGCATGCACAAAATTATGCTATGGAAAAATTGTTGCGTTT
TGATGGGAAACTGCGTAGCGTCTACAGTAGTCCCTTCTCGACGGTCTGTTCATTGGTCTTTCAGCTACCTTGCGCGTCT
TGGTAAACTGCACATAATTAACGCATGGAAATGTAAATTCTTTCCTGTTGGATAGTTTATGTTACCTCCCCTCCCCGCT
GTGAGAAACCAGTCTTGCGGCCCTTTGCTATTCAATTCTTTTACTCCGCACAAAACTGAGAGCTTCGATGCGCTGTGAA
CCGGTTATATTCTCTATCTGGTAAAATAAAATGTTTATTTAACTCGTGATCATTTTGATATCCTTATGAGACTCATAGT
TAGTTTTGCCTGTTTTTCCCAGAACTTTCTTTTGACAATGGCAATGTACCTGTTTCCATTGCCGCCTAACTTTTAACTT
TACGGAGGAAAAAATAACGAATGCTGAGAATATGAACTGCTGAGATTATGGGAGTGGGACACCC 
 
Figure 2. DNA sequence of SRY exon and PCR primers.  Contig from ECAY showing 
the SRY exon in bold lettering and the primers for the four overlapping fragments used 
for sequencing.  The first primer’s forward and reverse sequences are in yellow; the 
second in green; the third in blue; and the fourth in purple. 
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Equine SNP50 Beadchip Genotyping 
Animals H348 and H369 were closely related Standardbreds sharing a common 
grand-dam.  Their genome sharing value, p̂ = 0.1905, which is the degree of relatedness 
between two individuals, was calculated by pairwise clustering based on identity-by-
descent (IBD) using the PLINK Whole Genome Analysis Toolset software (Purcell 
2009).  They were selected for Equine SNP50 Beadchip (Illumina, Inc., San Diego, CA, 
USA) genotyping because of their relatedness and because whole-genome genotyping 
data was already available for 46 normal male Standardbreds (Drs. McCue and 
Mickelson; University of Minnesota; personal communication) unrelated to the two 
cases (the highest genome sharing value from pairwise clustering based on IBD from 
PLINK between a case and a control was p̂ = 0.1248).  The Equine SNP50 Beadchip 
features 54,602 SNPs that are evenly distributed across 15 different horse breeds with an 
average 43.2 kb space between probes for all 31 autosomes and the X chromosome.  
Beadchip genotyping was carried out by GeneSeek Inc. using 1 µg of genomic DNA 
from each case.  The data was analyzed using the PLINK software (Purcell 2009).  The 
data was analyzed using a basic association test (chi-square test for allele frequencies), 
and the results were visualized in Manhattan plots using Haploview v4.2 software 
(Barrett et al. 2005).  Regions of interest were analyzed using GO (Gene Ontology) from 
DAVID Bioinformatics Resources (Huang et al. 2009a, 2009b) and Gene Relationships 
Across Implicated Loci (GRAIL) (Raychaudhuri et al. 2009) to find functionally 
relevant candidate genes.   
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Candidate Gene Sequencing 
A candidate gene, NIPA-like domain containing 1 (NIPAL1), was selected for 
sequencing and mutation discovery.  Primers were designed for the first three exons of 
this gene using Primer 3 v0.4.0 software (Table 3), and the exons were sequenced in all 
five cases and a control (Bravo) using BigDye chemistry as described above.  The 
sequences were aligned with each other and the reference sequence (GenBank 
XM_001495264.1) using Sequencher v.4.7 software. 
 
Table 3. Primer sequences for NIPAL1 sequencing. 
 
 Forward Primer Reverse Primer Product Size (bp) 
Exon 1 5’-ACC TGT CCG AGA 
CTC CTC AG-3’ 
5’-GGT CTC ATC 
GCT ACC CAG AC-3’ 
205 
Exon 2 5’-TGT TTC AGT ACC 
ATC TAC GCA ACT-3’ 
5’-GCT CAA TCC 
TGG AAA CTG CT-3’ 
536 
Exon 3 5’-CTT CGA AGC TTC 
TTC CTC CA-3’ 
5’-TAC AAG CAA 
ACA CTA TTC TCA 
GCA-3’ 
150 
 
 
Array Comparative Genomic Hybridization (aCGH) 
The five cases were analyzed using the Texas-Adelaide equine whole genome 
oligonucleotide tiling array (Qu et al. 2011) The array is comprised of 417,277 60-mer 
oligonucleotides distributed in gene containing and non-genic sequences of the horse 
genome.  Average distance between the tiles on the array is 7.5 kb.  Array comparative 
genomic hybridization (aCGH) was carried out using Agilent Technologies’ (Santa 
Clara, CA, USA) aCGH protocol.  Briefly, 1 µg of the case genomic DNA and 1 µg of 
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the reference (male Thoroughbred Bravo) genomic DNA were digested with restriction 
enzymes, Alu I and Rsa I, at 37°C for 2 hours to fragment the DNA to about 200-500 bp 
fragment sizes.  The enzymes were inactivated at 65º for 20 min and cooled to 4ºC.  The 
DNA fragments were differentially labeled with fluorescent dyes using random primers 
and exo-Klenow enzyme.  The DNA from the cases was labeled with Cy5 fluorescent 
dye, which excites at 650nm and emits at 670nm; and the control DNA was labeled with 
Cy3 fluorescent dye, which excites at 550nm and emits at 570nm.  The labeling 
reactions used the following program: 37ºC for 2 hours, 65º for 10 min, 4ºC hold.  The 
labeled products were cleaned by adding 430 µL 1X TE buffer to each reaction and 
centrifuging twice through Amicon 30kDa filters (Millipore, Billerica, MA, USA) at 
13,000 rpm for 10 minutes.  The cleaned samples were collected by inverting the filters 
into fresh tubes and centrifuging at 1000 rpm for 1 minute, resulting in approximately 20 
µL of the product.  An additional 20 µL of 1X TE was added to the filter and collected 
by centrifuging at 1000 rpm for 1 minute.  DNA and dye concentrations of the labeled 
DNA were measured by Nanodrop spectrophotometry, and the genomic DNA yield and 
dye specific activity values were calculated using the following equations: genomic 
DNA yield = [DNA concentration (ng/µL) x sample volume (µL)]/1000 ng/µg; specific 
activity = (pmol per µL of dye)/(µg per µL genomic DNA).  Equal concentrations of the 
labeled case and reference DNA were mixed with 25 µL of horse Cot-1 DNA (1 
mg/mL), 26 µL of 10X blocking agent, and 130 µL of 2X Hi-RPM buffer, and the 
reactions were hybridized to the array for 40 hours at 65ºC in a Sure Hyb chamber 
(Agilent Technologies).  After hybridization, the array slides were disassembled in 
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Agilent wash buffer 1.  The slides were washed in Agilent wash buffer 1 for 5 minutes 
with agitation, Agilent wash buffer 2 at 37ºC for 2 minutes, acetonitrile for 10 seconds 
with agitation, and stabilizing/drying solution for 30 seconds with agitation.  All 
washing steps were carried out under stringent conditions to limit exposure to light, air, 
and ozone degradation.  The array slides were scanned on an Agilent SureScan DNA 
Microarray Scanner with 3µm resolution and XDR = 0.05, which takes the lightest and 
darkest areas of the image to more accurately represent the probe intensity levels across 
the array.  The data was extracted using Agilent’s Feature Extraction software.  CNV 
detection and analysis was carried out using Agilent’s Genomic Workbench v6.0 
software.  Significant gains and losses were determined by log2-threshold cutoffs of +0.5 
and -0.5, respectively, containing a minimum of five consecutive probes. 
 
Quantitative Real-Time PCR (qPCR) 
Two genomic regions containing CNVs in array CGH experiments were 
validated by qPCR using DNA from the five cases and five normal controls.  The two 
CNV regions were a cluster of olfactory receptor genes on ECA6 and a cluster of aldo-
keto reductase genes on ECA29.  Primers were designed around the two probes with the 
most significant “loss” scores: one region around the probe with the greatest “loss” value 
and two regions around the probe with the next greatest “loss” value (Table 4).  Primers 
were also designed for AKR1CL1 in the aldo-keto reductase gene cluster (Table 5).  All 
primers were designed using the Primer 3 v0.4.0 software.  Primer efficiency was 
evaluated by creating a standard curve using a DNA sample from one of the cases and 
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primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a reference gene.  
The qPCR reactions were carried out in duplicates using 50 ng of DNA from the five sex 
reversed horses and five controls (an Arabian, an Appaloosa, two Quarter Horses, and a 
Thoroughbred).  Each reaction contained 10 µL of Light Cycler® 480 Sybr Green 1 
Master Mix (Roche Diagnostics, Mannheim, Germany), 1 µL of 10 µM forward or 
reverse primers, 8 µL of ddH2O, and 2 µL of DNA (50ng).  Copy numbers were 
evaluated using qPCR on a Light Cycler® 480 (Roche Diagnostics, Mannheim, 
Germany).  Results were analyzed by calculating log2-ΔCt, and the p-value was calculated 
by performing Student’s t-test; any p-value <0.05 was considered to be significant. 
 
Table 4. Primer sequences for an olfactory receptor gene for qPCR.  The regions on 
ECA6 were selected based on the log2 ratio of the probes.  The 60-mer probes are 
contained in the products. 
 
Region Probe Score Forward Primer 
5’-3’ 
Reverse Primer 5’-
3’ 
Product Size 
(bp) 
1 -1.694 TCT CAT CCC 
TAC ACC TTC 
TGG 
ATT GGA GGT 
GGG GTA GGA 
AG 
249 
2 -1.576 TTC CAC ATT 
AAT CAG CAG 
ATG G 
TGC GGA TGC 
ACA TAA AGA 
AG 
173 
3 -1.576 CGC AAT GAA 
TGG AAG ATG 
AA 
GAT CCA AAC 
AAC AGC AGC 
AA 
228 
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Table 5. Primer sequences for AKR1CL1 for qPCR and FISH 
 
Exon Forward Primer 5’-3’ Reverse Primer 5’-3’ Product Size (bp) 
1 CCC CAG TGA CAG 
TGG ATT CT 
GGT CCG AGA TCA 
AGG ATG AA 
217 
2 CAG CTT CCA GTC 
AGG GAA AG 
TTT GCA TTC AAC 
CCT CCA GT 
187 
3 CTC CTC TCC GAG 
TCA GAT GG 
CAG CAC CTT GGT 
CGT GTA GA 
225 
 
 
Screening the Equine Bacterial Artificial Chromosome (BAC) Library and BAC DNA 
Isolation 
A massive deletion including a cluster of an aldo-keto reductase gene family on 
ECA29 in two of the sex reversed cases was further verified by fluorescence in situ 
hybridization (FISH) using BACs containing the genes of interest.   The corresponding 
BACs were identified from the equine CHORI-241 BAC library 
(http://bacpac.chori.org/equine241.htm) by screening the library superpools and plate 
pools by PCR using primers for AKR1CL1 (Table 5).  The BACs were grown overnight 
at 37°C in 2YT media (Invitrogen, Carlsbad, CA, USA) containing chloramphenicol (30 
mg/mL) and plated on LB agar (Invitrogen, Carlsbad, CA, USA) containing 
chloramphenicol.  Clones were grown overnight at 37°C, single colonies were picked 
and incubated in 2YT media containing chloramphenicol for 8 hours.  The identity of the 
single colonies was once again verified by PCR, which was carried out on cell lysates, 
and the final positive clones were grown in 100 mL of 2YT containing chloramphenicol 
at 37°C overnight.  The BAC DNA was isolated using the Plasmid Midi Kit (Qiagen, 
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Valencia, CA, USA) following the manufacturer’s protocol.  Briefly, the 100 mL 
cultures were divided into two 50 mL tubes and centrifuged at 8000 rpm and 4°C for 30 
minutes.  The supernatant was discarded, and the pellet was re-suspended in 10mL of 
Qiagen P1 buffer containing RNase A (100 µg/mL).  Next, the samples were incubated 
for 5 minutes in 10 mL of Qiagen P2 buffer on ice with constant inverting.  Finally, the 
P2 buffer was neutralized by adding 10 mL of cold Qiagen P3 buffer and incubated on 
ice for 15 minutes with occasional inverting.  The samples were centrifuged at 8000 rpm 
and 4°C for 30 minutes, the supernatant was filtered through 3 layers of coffee filters 
into fresh 50 mL tubes, and passed through Qiagen-tip 100 columns, which were 
equilibrated with Qiagen QBT buffer.  The columns were washed with Qiagen QC 
buffer twice, and the DNA was eluted with 5 mL of Qiagen QF buffer (prewarmed to 
65°C and added in 1 mL aliquots) into fresh 50 mL tubes.  Equal volume of isopropanol 
was added to the 5 mL of eluted DNA for precipitation.  The samples were centrifuged 
at 8000 rpm and 4°C for 30 minutes, and the supernatant was discarded.  The DNA 
pellet was washed with 70% ethanol, transferred into 1.5 mL microcentrifuge tubes, and 
centrifuged at 13,000 rpm for 15 minutes.  The pellet was washed with 70% ethanol, air-
dried, and re-suspended in ddH2O.  DNA quality was checked bye Nanodrop 
spectrophotometry and electrophoresis on a 1% agarose gel. 
 
Fluorescence in situ Hybridization (FISH) 
Probe labeling, in situ hybridization, detection, microscopy, and image analysis 
were carried out according to the detailed protocol by Raudsepp and Chowdhary (2008). 
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Briefly, 1 µg of the BAC DNA was labeled with either biotin (BIO) or digoxigenin 
(DIG) using BIO- or DIG-nick translation mix (Roche Diagnostics), respectively.  
Following incubation at 15°C (1 hour 10 minutes for BIO; 1 hour 30 minutes for DIG), 
the labeling reactions were cleaned using Sephadex Spin-50 mini columns and checked 
on a 1% agarose gel.  In order to bind non-specific repetitive sequences, 10 µL of 
unlabeled horse genomic DNA (1 µg/µL) was added to the labeled probe, concentrated 
in a vacuum centrifuge, and re-suspended in 3:7 water:hybridization master mix.  The 
latter contained 70% deionized formamide (molecular biology grade, Sigma Aldrich, St. 
Louis, MO, USA), 14% dextran sulphate sodium salt (Sigma Aldrich), and 3X SSC.  
Slides with metaphase chromosome spreads were treated with RNase (100 µg/mL in 2X 
SSC) (Fisher Scientific) at 37°C for 1 hour, denatured in 70% formamide; 2X SSC (pH 
7.0) at 70°C for 2 minutes, dehydrated in an ascending series of 70%, 80%, 90%, and 
100% ethanol, and air-dried.  The probes were denatured at 90°C for 12 minutes, pre-
annealed at 37°C for 20 minutes, and applied to the slides under coverslips.  
Hybridizations were carried out in a moist chamber at 37°C overnight.  The next day, the 
slides were washed three times in 50% formamide; 2X SSC at 40°C for 5 minutes each, 
three times in 4X SSC; 0.05% Tween-20 at room temperature for 2 minutes each with 
gentle shaking, and in 4X SSC at room temperature for 2 minutes with gentle shaking.  
Antibodies were diluted in 1X blocking solution (Vector Laboratories) and pooled 
together because biotin- and dig-labeled probes were co-hybridized on the same slide.  
For the first antibody layer, fluorescein-avidin D (avidin-FITC; Vector Laboratories) 
was used to tag biotin, and mouse antidig (Roche Biochemicals) was used to tag DIG.  
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Antibodies were incubated at 37°C for 30 minutes.  The slides were washed three times 
in 4X SSC; Tween20 and once in 4X SSC as described above.  For the second antibody 
layer, biotinylated antiavidin D (Vector Laboratories) was used to tag the avidin-FITC 
on BIO, and antimouse Ig-dig (Chemicon International, Billerica, MA, USA) was used 
to tag the antidig on DIG.  After 30 minutes of incubation at 37°C, the slides were 
washed as described above.  For the third layer, avidin-FITC was used to tag the 
biotinylated antiavidin D and add additional fluorochromes for better biotin signal 
detection, and antidig-rhodamine (Roche Biochemicals) was used to tag the antimouse 
Ig-dig for DIG signal detection.  Lastly, the slides were mounted with DAPI-antifade.  
The results were analyzed with a Zeiss Axioplan2 fluorescent microscope using DAPI, 
FITC, and Cy3 fluorescent filters, and the images were captured using Isis v5.2 
(MetaSystems GmbH) software.  For each hybridization, 10-15 cells were analyzed. 
 
PCR Refinement to Define the ECA29 Deletion Breakpoints 
 Defining the breakpoints of the massive deletion on ECA29 in H348 and H369 
was initiated by designing primers flanking the deletion directly outside of the deletion 
and immediately inside the deletion start site and inside the deletion end site (Table 6, 
Fig. 3) using the Primer 3 v0.4.0 software.  Repetitive sequences in the region present in 
other regions of the genome were masked using RepeatMasker (Smit et al. 1996-2010; 
http://www.repeatmasker.org/) to ensure unique primers that only amplify the region on 
ECA29.  Genomic DNA from all five cases, a male control (Bravo), and a female 
control (Twilight) was amplified by PCR.  The 10 µL PCR reactions contained 0.25 unit 
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Taq polymerase, 50 mM KCl, 10 mM Tris-HCl (pH 8.4), 0.2 mM dATP, dCTP, dTTP, 
and dGTP, 0.3 µM of each primer, and 50 ng of genomic DNA as a template.  The DNA 
was denatured at 95°C for 30 seconds, annealed at 60°C for 30 seconds, extended at 
72°C seconds, followed by amplification for 30 cycles using the following program: 
94°C for 30 seconds, 58°C for 30 seconds, 72°C for 30 seconds.  The final extension 
was at 72°C for 10 minutes.  The PCR products were resolved on 1% agarose gels 
containing ethidium bromide. 
 
Table 6. Primer sequences for defining the ECA29 deletion breakpoints.  Primers were 
designed for the region immediately outside of the deletion and the regions immediately 
inside the deletion start and end site. 
 
Region Forward Primer 5’-3’ Reverse Primer 5’-3’ Product 
Size (bp) 
OUT (Region 
outside of 
deletion) 
ACC CCA CCC ACC 
CTA TAT GT 
CAT ATG GGG GTG 
ACA GGA AT 
226,069 
DEL.IN1 (Region 
inside deletion 
start site) 
CCC ATG GCT GTG 
GAA CTA GA 
ATC ACC TGC CCT 
TCA CAC TC 
180 
DEL.IN2 (region 
inside deletion 
end site) 
TGA TTT GCT TGG 
ATT TTC TGG 
TGT GCA GAA AAA 
TAC CGA AGA TT 
154 
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Figure 3. Primers designed around the ECA29 deletion site to define the breakpoints. 
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RESULTS 
 
Cytogenetic Analysis and SRY Testing 
Cytogenetic analysis of Giemsa stained metaphase spreads showed that the five 
cases had normal diploid chromosome number (2n=64), but the XY chromosome 
complement, which is typical of males (Fig. 4a, b).  The results were confirmed by C-
banding, which clearly showed the presence of one X chromosome and one Y 
chromosome (Fig. 4c).  Amplification by PCR of the SRY gene was observed in all five 
animals, thus confirming the presence of the Y chromosome and the male sex 
determination gene (Fig. 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Cytogenetic analyses.  A Giemsa stained metaphase spread (a), a karyotype 
(b), and a C-banded metaphase spread (c) of an SRY-positive XY sex reversed female 
horse. 
a) 
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Figure 4. Continued 
 
b) 
c) 
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Figure 5. PCR gel image for SRY product.  Gel image showing the presence of SRY PCR 
product (131 bp) in an XY female and male control but not in normal female control. 
 
 
 
SRY Sequencing 
Sequence analysis of the SRY exon and predicted promoter region revealed 99-
100% similarity between the five cases, the normal male control, and the reference 
sequence (Fig. 6).  These results effectively excluded mutations in the SRY gene as a 
possible cause of the sex reversal condition. 
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Figure 6. DNA sequence alignment of SRY.  The alignments show identical sequences 
between a male control and the five cases.  The region corresponds to Fragment 2 in 
Table 2 including the predicted promoter sequence and part of the SRY exonic sequence. 
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SNP50 Beadchip Genotyping and Data Analysis 
Good quality (97-98%) equine SNP50 Beadchip genotypes were obtained for 
H348 and H369 and the 46 normal male Standardbred horses.  Allele frequencies 
between the two cases and controls were analyzed using basic association (chi-square) 
tests and PLINK software.  For the initial, non-permuted data, SNPs above the threshold 
cutoff p-value of -log10>6 were considered statistically significant and were observed in 
five horse chromosomes: ECA3, 6, 11, 12, and 28 (Fig. 7a).  The initial data were 
corrected by 10,000 permutations, and two statistically significant SNPs were retained 
above the threshold cutoff p-value of -log10>1.5 on ECA3 (Fig. 7b).  Both retained SNPs 
were located on the long arm (ECA3q) at base pair positions 64,917,308 and 80,911,978 
both with p-value = 9.13E-11.   
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Figure 7. Manhattan plots of genotyping results.  The plots show significant SNPs using 
non-permuted data (a) and permuted data (b). 
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Candidate Gene Discovery and Sequencing 
The distance between the two SNPs on ECA3q was 16 megabase-pairs (Mb), 
which is very large for targeting candidate genes.  Candidate genes were searched for in 
1 Mb regions up- and downstream from the SNPs using Ensembl Genome Browser 
(http://useast.ensembl.org/index.html; Fig. 8a, b) and GRAIL (Raychaudhuri et al. 
2009).  Searching 1 Mb up- and downstream of the SNPs in Ensembl revealed the two 
~2 Mb regions were relatively gene poor, harboring 25 and 18 protein coding genes, 
respectively (Fig. 8).  Analysis using GRAIL mined 26 genes from the first SNP and 15 
from the second SNP (Table 7).  The entire 16 Mb region was also analyzed using 
GRAIL and Gene Ontology (GO) (Huang et al. 2009a, 2009b) to cluster the genes based 
on function.  The combined analysis identified 52 candidate genes (Table 8).  Of these, 
NIPA-like domain containing 1 (NIPAL1), a membrane-related magnesium transporter, 
was selected for exon sequencing and mutation discovery.  Sequencing the first three 
exons and exon-intron boundaries identified two SNPs in non-coding regions: a G to A 
transition at base pair position 80,901,305 preceding the start of exon 1 (Fig. 9) and a 
C/A polymorphism at base pair position 80,892,949 in intron 1, near the intron 1/exon 2 
boundary (Fig. 10).  Notably, in the first SNP site, H348 and H369 were heterozygous 
for the G/A allele while the remaining cases were homozygous for the G allele (Fig. 9).  
All five cases and the male control were heterozygous for the second SNP.  Neither SNP 
was recorded in the Broad Institute database for Horse SNPs (http://www.broadinstitute 
.org/mammals/horse/snp).  No SNPs were found in the coding exons.
 
 
 
39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Ensembl Genome Browser depicting genes 1 MB up- and downstream of the SNPs on ECA3.  Region 1 Mb up- and 
downstream of the SNP at base pair position 64,917,308 on ECA3 contains 25 protein coding genes, 3 pseudogenes, and 2 
processed transcripts (a), and region 1 Mb up- and downstream of the SNP at base pair position 80,911,978 on ECA3 contains 
18 protein coding genes, 5 pseudogenes, 1 RNA gene, and 1 processed transcript.
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Table 7. Genes mined by GRAIL around the two SNPs on ECA3.  Regions 1 Mb up- 
and downstream of the two SNPs on ECA 3 at base pair positions 64,917,308 (SNP1) 
and 80,911,978 (SNP2) were analyzed.  This returned 26 GRAIL and 25 Ensembl genes 
for SNP1, and 15 and 18 genes for SNP2.  Of these, 16 and 14 genes were common 
between the two analyses for SNP1 and SNP2, respectively. 
 
GRAIL Results for SNP 
at 64,917,308 
Ensembl Results for SNP 
at 64,917,308 
Both 
AMBN AMBN AMBN 
AMTN AMTN AMTN 
C4orf7 CABS1 CSN1S1 
C4orf35 CSN1S1 CSN2 
C4orf40 CSN2 CSN3 
CSN1S1 CSN3 ENAM 
CSN2 DCK ODAM 
CSN3 ENAM SMR3A 
ENAM GRSF1 SULT1E1 
HTN1 IGJ UGT2A1 
HTN3 MOBKL1A UGT2A3 
MUC7 ODAM UGT2B10 
ODAM RUFY3 UGT2B11 
PROL1 SMR3A UGT2B28 
SMR3A SULT1E1 UGT2B4 
SMR3B UGT2A1 UGT2B7 
STATH UGT2A3  
SULT1B1 UGT2B10  
SULT1E1 UGT2B11  
UGT2A1 UGT2B15  
UGT2A3 UGT2B17  
UGT2B10 UGT2B28  
UGT2B11 UGT2B4  
UGT2B28 UGT2B7  
UGT2B4 UTP3  
UGT2B7   
   
GRAIL Results for SNP 
at 80,911,978 
Ensembl Results for SNP 
at 80,911,978 
Both 
ATP10D ATP10D ATP10D 
CNGA1 CNGA1 CNGA1 
COMMD8 COMMD8 COMMD8 
CORIN CORIN CORIN 
FLJ21511 CWH43 GABRB1 
GABRB1 DCUN1D4 NFXL1 
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Table 7. Continued 
GRAIL Results for SNP 
at 80,911,978 
Ensembl Results for SNP 
at 80,911,978 
Both 
NFXL1 FRYL NIPAL1 
NIPAL1 GABRA4 OCIAD1 
OCIAD1 GABRB1 OCIAD2 
OCIAD2 NFXL1 SLAIN2 
SLAIN2 NIPAL1 SLC10A4 
SLC10A4 OCIAD1 TEC 
TEC OCIAD2 TXK 
TXK SLAIN2 ZAR1 
ZAR1 SLC10A4  
 TEC  
 TXK  
 ZAR1  
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Table 8. Genes mined by GRAIL between the two SNPs on ECA3.  The 16 Mb region 
was submitted to GRAIL, and the region was also manually analyzed from the Ensembl 
Genome Browser.  Genes present in both lists were analyzed by function using Gene 
Ontology (GO).  Functionally relevant genes from GO are denoted by an asterisk 
 
GRAIL Ensembl Both 
AASDH 1700023E05Rik AASDH 
AMBN AASDH ARL9 
AMTN AC068620.2 C4orf14 
ARL9 ARL9 CENPC1 
C4orf14 C4orf14 CEP135 
C4orf35 CENPC1 CHIC2 
C4orf40 CEP135 CLOCK 
C4orf7 CHIC2 CSN2 
CENPC1 CLOCK DCUN1D4 
CEP135 CSN2 EPHA5* 
CHIC2 CWH43 EXOC1 
CLOCK DCUN1D4 FIP1L1 
CNGA1 EPHA5 FRYL 
CORIN EXOC1 GNRHR* 
CSN1S1 FIP1L1 HOPX 
CSN2 FOLR1 IGFBP7 
CSN3 FRYL KDR* 
DCUN1D4 GNRHR KIAA1211 
ENAM HOPX KIT* 
EPHA5 IGFBP7 LNX1 
EXOC1 KDR LPHN3 
FIP1L1 KIAA1211 NMU 
FLJ21511 KIT NIPAL1* 
FRYL LNX1 OCIAD1 
GNRHR LOC518437 OCIAD2 
GSX2 LPHN3 PAICS 
HOPX LRRC66 PDCL2 
HTN1 NIPAL1 PDGFRA* 
HTN3 NMU POLR2B 
IGFBP7 OCIAD1 PPAT 
IGJ OCIAD2 RASL11B 
KDR PAICS REST 
KIAA1211 PDCL2 SCFD2 
KIT PDGFRA SGCB* 
LNX1 POLR2B SCL10A4 
LPHN3 PPAT SPATA18 
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Table 8. Continued 
GRAIL Ensembl Both 
MUC7 Q1L836_BOVIN SPINK2 
NFXL1 RASL11B SRD5A3 
NMU REST SRP72 
NIPAL1 SCFD2 STAP1 
OCIAD1 SGCB SULT1E1 
OCIAD2 SLC10A4 TMEM165 
ODAM SN1S1 TMPRSS11A* 
PAICS SNORA31 TMPRSS11B* 
PDCL2 SPATA18 TMPRSS11D* 
PDGFRA SPINK2 TMPRSS11E2 
POLR2B SRD5A3 TXK 
PPAT SRP72 UBA6 
PROL1 STAP1 UGT2A3 
RASL11B SULT1E1 UGT2B10 
REST TECRL YTHDC1 
SCFD2 TMEM165 ZAR1 
SGCB TMPRSS11A  
SLAIN2 TMPRSS11B  
SLC10A4 TMPRSS11D  
SMR3A TMPRSS11E2  
SMR3B TMPRSS11F  
SPATA18 TXK  
SPINK2 UBA6  
SRD5A2L2 UGT1A6  
SRD5A3 UGT2A3  
SRP72 UGT2B10  
STAP1 YTHDC1  
STATH ZAR1  
SULT1B1   
SULT1E1   
SYT14L   
TEC   
TMEM165   
TMPRSS11A   
TMPRSS11B   
TMPRSS11D   
TMPRSS11E   
TMPRSS11E2   
TXK   
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Table 8. Continued 
GRAIL Ensembl Both 
UBA6   
UGT2A1   
UGT2A3   
UGT2B10   
UGT2B11   
UGT2B15   
UGT2B17   
UGT2B28   
UGT2B4   
UGT2B7   
USP46   
YTHDC1   
ZAR1   
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Figure 9. DNA sequence alignment of part of the first exon of NIPAL1.  The start of the 
first exon is indicated by the red arrow.  The sequence alignment shows a SNP in H348 
and H369 in the non-coding region immediately preceding the first exon, indicated by 
the red circles. 
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Figure 10. DNA sequence alignment of part of the second exon of NIPAL1.  The start of 
exon 2 is indicated by the red arrow.  This sequence alignment shows a C/A 
heterozygous position in all of the cases and male control indicated by the red circle. 
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The Discovery of Structural Rearrangements Using Array Comparative Genomic 
Hybridization (aCGH) 
The quality of aCGH raw data was evaluated based on the derivative log ratio 
standard deviation (DLRSD) score, which calculates the noise level by measuring the 
distance between each spot and taking the standard deviation to acquire a baseline for 
detecting gains and losses.  A lower DLRSD value equates to less noise, thus only 
results with DLRSD <0.30 were used for further analysis (Table 9).  The DLRSD scores 
were acceptable for all but one of the SRY-positive XY sex reversed females.  The mixed 
warmblood, H252, consistently produced poor results in three separate aCGH 
experiments and was thus excluded from the array data set.  
Altogether, 187 CNVs were detected in the genomes of the four sex reversed 
animals (H169, H348, H369, and H423) in relation to the normal male Thoroughbred 
reference genome.  Of these, 126 were gains, and 61 were losses.  The CNVs were 
distributed over all autosomes and the X chromosome, with the exception of ECA22 and 
the Y chromosome, which showed no gains and losses in the studied individuals (Figs. 
11 & 12).  Distribution of CNVs along individual chromosomes (Fig. 11) shows that 
genomic gains and losses occur at both G-positive and G-negative bands, intercalary, 
and at the pericentromeric and subtelomeric regions.  The number of CNVs per 
chromosome (Fig. 12) ranges from 14 on ECA1 to 2 on ECA13, 14, 18, 21, and 28-31, 
thus being overall correlated with the chromosome size.  However, chromosomes 7, 10, 
12, 16, and 20 showed a disproportionately high number of CNVs compared to the 
chromosome size (Fig. 12).  Structural variants (n=5) were also found in the unassigned 
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sequences (chromosome Un).  The size of the detected CNVs ranged from 1 kb to 
almost 3,500 kb, while approximately half of all the CNVs were in the size range of 10-
300 kb (Fig. 13).  
Analysis of aCGH results for individual animals revealed differences in the 
number and distribution of CNVs in the four sex reversed horses.  The highest number 
of CNVs was detected in one of the Standardbreds (H348) and the least in the Appaloosa 
horse (H169) (Fig. 14).  However, only a few CNVs were shared between the cases (Fig. 
15).  As expected, the two related Standardbreds, H348 and H369, had similar array 
results showing 25 common CNVs: 23 duplications and 2 deletions (Fig. 15).  In 
contrast, there were only four common structural variants between the Appaloosa 
(H169) and one or the other Standardbred.  Of these, a loss containing CUB and Sushi 
multiple domains 1 gene (CSMD1) on ECA27 was shared between the three animals.  
Further, the Appaloosa (H169) shared three losses and one gain with the Quarter Horse 
(H423), while only one common CNVs was detected between the latter and the two 
Standardbreds despite the fact that all three were classified as male 
pseudohermaphrodites.  The only region containing a CNV commonly shared between 
all four cases was on ECA1, although the CNV was a deletion in H169, H348, and H369 
and a duplication in H423. 
Many of the largest CNVs contained clusters of olfactory receptor genes; other 
types of genes found in the CNVs included major histocompatibility complex (MHC) 
genes, immunity-related genes, muscle and skeletal genes, solute carrier genes, keratins, 
LINE1 associated reverse transcriptases, and a variety of others.  Genes that appeared 
 
 
 
49 
more functionally relevant included a meiosis-specific nuclear structural 1 (MNS1) gene 
and a testis expressed 9 (TEX9) gene both in the same CNV region on ECA1.  Overall, 
41% of the CNVs contained coding genes, and the remaining 59% contained non-genic 
regions (Fig. 16). 
Out of all of the CNVs, the functionally most interesting and relevant CNV was a 
massive (>225 kb) deletion on ECA 29 at 28,593,238-28,818,472 Mb found in H348 and 
H369, the two related Standardbreds (Fig. 17).  The CNV contained a cluster of genes 
from the aldo-keto reductase gene family, which is known to catalyze the reactions to 
inter-convert sex hormones (testosterone and progesterone) into their active and inactive 
forms (Jin et al. 2011).  However, the deletion was not observed in H169 or H423. 
 
Table 9. Derivative log ratio standard deviation scores (DLRSD).  The DLRSD scores 
for aCGH experiments were calculated by Agilent’s Genome Workbench for the five sex 
reversed female horses. 
 
Case DLRSD Score 
H169 0.190 
H252 0.467 (average for three experiments) 
H348 0.223 
H369 0.189 
H423 0.154 
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a) CNVs across all four cases 
 
 
Figure 11. G-banded ideograms of CNV distribution.  Ideograms include the horse 
autosomes, the sex chromosomes, and unassigned (Un) regions.  Chromosome numbers 
are shown at the top of each ideogram.  CNV distribution is shown across all four cases 
(a), as well each individual animal, H169 (b), H348 (c), H369 (d), and H423 (e). 
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b) H169 
 
 
Figure 11. Continued 
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c) H348 
 
Figure 11. Continued 
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d) H369 
 
Figure 11. Continued 
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e) H423 
 
Figure 11. Continued 
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Figure 12. Bar graph of CNVs per chromosome. 
 
 
 
 
 
 
 
 
 
Figure 13. Distribution of CNVs by size. 
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Figure 14. Number of CNVs per case. 
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Figure 15. Shared CNVs between the cases. 
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Figure 16. Distribution of CNVs containing coding genes and non-genic regions. 
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Figure 17. Array CGH image of deleted region on ECA29.  The deletion was observed 
in H348 and H369, indicated by the box with the green outline.  Each dot in the figure 
corresponds to a 60-mer oligonucleotide on the array.  Normal copy number values are 
represented by the black dots along the middle, and deviations from the normal values 
are represented by either the red dots (gains) or the green dots (losses).  Genes within the 
region are indicated by the gray text. 
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Array CGH Data Validation by Quantitative Real-Time PCR (qPCR) 
Quantitative Realtime PCR (qPCR) was used to confirm and measure the loss of 
DNA copy number levels in all five sex reversed cases compared to five normal male 
controls.  Two regions from the aCGH results were selected for qPCR testing: an 
olfactory receptor gene cluster on ECA6 and a massive deletion on ECA29 containing a 
family of aldo-keto reductase genes.  Although aCGH results were not available for the 
mixed warmblood, H252, genomic DNA was available for qPCR, thus it was included in 
this part of the experiment.  The normal male controls were selected based on their 
breeds in order to compare them to the cases, thus two Quarter Horses and one 
Appaloosa were used, plus an Arabian and a Thoroughbred (Bravo) because a normal 
male Standardbred and a normal male mixed warmblood were not available.  Standard 
curves were successfully calculated from the technical replicates from the first two 
primer sets but were not usable for the third primer.  Therefore, the results were only 
available for the first two regions in the olfactory receptor gene cluster on ECA6 (see 
Table 4).  As expected, DNA copy numbers were lower in the five cases compared to the 
controls for the olfactory receptor region on ECA6 (Fig. 18) thus validating the deletion 
observed by aCGH for H169, H348, H369, and H423 and also expanding this to H252.  
The calculated p-value for the first region was 3%, and the calculated p-value for the 
second region was 8% (Table 10); p-values <5% were considered highly significant. 
Quantification of gene copy numbers by qPCR in the second region of interest, 
the aldo-keto reductase gene cluster on ECA29, gave no results because AKR1CL1 was 
completely deleted in H348 and H369.  Likewise, regular PCR with AKR1CL1 primers 
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produced no amplification product in H348 and H369, while the sequence was 
successfully amplified in H169, H252, and H423, and in a male and a female control 
(Fig. 19).  Altogether, the qPCR and PCR results were in agreement with the aCGH data 
and confirmed the findings. 
 
Table 10. P-value scores for olfactory receptor gene regions in qPCR.  Values <0.05 
were considered highly significant. 
 
Sample P-value 
Region 1 0.031195 
Region 2 0.081011 
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Figure 18. Fold induction between cases and controls from qPCR.  Bar graphs are on a 
log scale. 
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Figure 19. PCR products using AKR1CL1 primers.  The conventional PCR products are 
seen in all five cases and male and female control for the primers from AKR1CL1 
validating the deletion in H348 and H369. 
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Array CGH Data Validation by Fluorescence in situ Hybridization (FISH) 
 FISH was used to confirm and refine the massive deletion of aldo-keto reductase 
genes on ECA29 in animals H348 and H369.  Metaphase chromosome preparations were 
obtained from all sex reversed horses, except H252.  Metaphase spreads from a normal 
male horse were used as a control.  Dual color FISH was carried out with the BAC 
clones (23N13, 67D20, 161K5, and 177J11) for the AKR1CL1 gene and a control gene, 
CREM.  The latter maps to a different region on ECA29 (q13, Raudsepp et al. 2008) and 
is not involved in any CNVs.  Good quality FISH signals on both homologues were 
obtained with CREM and all four AKR1CL1 BACs in H169, H423, and the control horse 
(Fig. 20).  In cases H348 and H369, good signals on both homologues were only seen 
with CREM while signals with AKR1CL1 clones 67D20 and 161K5 were consistently 
weaker than the CREM signal (Fig. 21) or the signals produced by the two AKR1CL1 
BACs in other animals.  Notably, no FISH signals on the metaphase spreads of animals 
H348 and H369 were obtained with BACs 23N13 and 177J11 (Fig. 22).  Alignment of 
the ends of the four AKR1CL1 BAC clones with EquCab2 reference sequence showed 
that clones 23N13 and 177J11 only contain sequences within the deletion, while the 
sequences in clones 67D20 and 161K5 also extend out of the deletion (Fig. 23).  This 
explains why clones 67D20 and 161K5 produced weak FISH signals and why no signals 
were observed with clones 23N13 and 177J11 in the two Standardbred horses.  The 
FISH analysis thus further confirmed the aCGH and PCR results, but additionally 
refined the results showing that the deletion in the two Standardbreds is homozygous and 
that the deletion breakpoints are contained in clones 67D20 and 161K5. 
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Figure 20. FISH on a normal male control using CREM and BAC 23N13.  The FISH 
results show strong signals from CREM (red signal, red arrows), a control gene known to 
be mapped to the distal end of ECA29, and BAC 23N13 (green signal, green arrows), 
which is located within the deletion. 
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Figure 21. FISH on H369 using CREM and BAC 67D20.  The FISH results on a 
metaphase spread of H369 show a strong signal for CREM (red signal, red arrows) on 
ECA29 and a weaker signal for BAC 67D20 (green signal, green arrows), which is 
located only partially in the deletion on ECA29. 
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Figure 22. FISH on H369 using CREM and BAC 23N13.  The FISH results on a 
metaphase spread of H369 show a strong signal for CREM (red signal, red arrows) on 
ECA29 and an absence of green signal for BAC 23N13, which is located inside the 
deleted region. 
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Figure 23. Schematic showing the deletion on ECA29 and the relative positions of the BACs.  The location of the deletion is 
shown on an ideogram of ECA29 (red bar), the genes present within the deletion are indicated by the yellow bars, and the 
positions of the BAC clones respective to the deleted region are indicated by the gray bars. 
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PCR Refinement to Define the ECA29 Deletion Breakpoints 
 
 PCR was used to amplify regions inside and around the massive deletion on 
ECA29 using genomic DNA from H348, H369, a male control (Bravo), and a female 
control (Twilight).  Primers immediately after the deletion start site (“DEL.IN1”, Figs. 3 
& 24a) and immediately before the deletion end site (“DEL.IN2”, Figs. 3 & 24b) did not 
amplify in H348 and H369 but were successfully amplified in the two controls.  A 
forward primer immediately preceding the deletion start site (“OUT”) was combined 
with the reverse primer of “DEL.IN1,” and no PCR product was observed in H348 and 
H369 while PCR product was present for the two controls (Fig. 24c).  Similarly, the 
forward primer from “DEL.IN2” was combined with a reverse primer immediately 
following the deletion end site (“OUT”), and no PCR product was observed in H348 and 
H369 while PCR product was present for the two controls (Fig. 24d).  Notably, no PCR 
product was obtained with the “OUT” forward and reverse primers in any of the horses 
analyzed. 
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Figure 24. PCR results for primers designed in and around the ECA29 deletion.  
“DEL.IN1” did not amplify in H348 and H369 immediately after the deletion start site 
but did amplify in the two controls (a); “DEL.IN2” did not amplify in H348 and H369 
immediately preceding the deletion end site but did amplify in the two controls (b); a 
forward primer immediately preceding the deletion start site (“OUT”) and reverse primer 
from “DEL.IN1” did not amplify in H348 and H369 but did amplify in the two controls 
(c); forward primer from “DEL.IN2” and a reverse primer immediately following the 
deletion end site (“OUT”) did not amplify in H348 and H369 but did amplify in the two 
controls (d). 
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Figure 24. Continued 
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Figure 24. Continued 
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Figure 24. Continued 
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DISCUSSION 
 
The search for genetic factors underlying mammalian sex determination has 
lasted for decades.  It is well established that sex in mammals is determined in the fetal 
gonad by the presence or absence of the Y chromosome gene, SRY (Gubbay et al. 1990; 
Sinclair et al. 1990; Koopman et al. 1991).  This initial trigger activates a complex 
regulatory gene network, which involves autosomal and X-linked genes, bending the 
balance either towards male or female sexual development (Matson et al. 2011; Migeon 
& Wisniewski 2003; Bagheri-Fam et al. 2010; Piprek 2009).  Though the molecular 
details of these processes are not fully understood, it is generally agreed that mammalian 
sex determination is a dynamic and multidimensional process making identification of 
genes and non-genic factors involved challenging.  It is therefore of no surprise that very 
little is currently known about the underlying genetics of abnormal sexual development, 
for example, the male-to-female XY sex reversal syndrome. 
In this study, the molecular genetic causes of XY sex reversal syndrome in 
horses were investigated.  Although SRY is known to be the main trigger for male sex 
determination, the XY sex reversal condition in horses (Kent et al. 1986; Makinen et al. 
1999; Bugno et al. 2003; Switonski et al. 2005; Raudsepp et al. 2010) and other 
mammalian species (Michala et al. 2008; Ferrer et al. 2009; Villagomez et al. 2009) 
involves both SRY-negative and SRY-positive cases.  While Y chromosome deletions 
explain the molecular background of SRY-negative cases in horses (Raudsepp et al. 
2010), the genetic causes of the SRY-positive sex reversal remain as of yet undetermined.  
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Given the complexity of genetic regulation of mammalian sex determination, successful 
research in this field needs the use of global (genome-wide) analysis tools, which very 
recently have become available for domestic species, including the horse.  Taking 
advantage of the draft genome sequence assembly (Wade et al. 2009), the SNP50 
Beadchip (McCue et al. 2009), and the 400K whole genome tiling array (Qu et al. 2011), 
the SRY-positive XY sex reversal condition in the horse was investigated for the first 
time by combining the traditional cytogenetic and candidate gene analyses with whole-
genome studies. 
 
Cytogenetics of Sex Reversal 
 Cytogenetic analysis has been and still is the “gold standard” for the initial 
detection of the sex reversal condition in horses or any other mammalian species.  This 
is because identifying the sex chromosome complement in the karyotype will determine 
whether or not there is a discrepancy between the phenotypic and genetic sex.  Likewise 
in this study, the initial identification of the five horses as sex reversals was done 
through chromosome analysis showing that these five female or female-like animals had 
64,XY karyotypes. 
 
The Y Chromosome and SRY 
 Because the sex determining region on Y (SRY) is the primary trigger for male 
sexual development, the next logical step was to determine the presence or absence of 
the SRY gene on the Y chromosome of the five abnormal horses by PCR.  Such tests 
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have been used in horses since the SRY sequence became available (Hasegawa et al. 
1999) and show that the female-like phenotype or the lack of male phenotype in the 
majority of sex reversed animals is primarily due to the loss of SRY (Pailhoux et al. 
1995; Makinen et al. 1999; Raudsepp et al. 2010).  In this light, the findings of the 
present study were of particular interest because all five animals were positive for the 
SRY gene.  Previously, the SRY-positive sex reversal in horses had been reported in only 
two studies (Switonski et al. 2005; Raudsepp et al. 2010), in which no mutations in the 
SRY sequence were found, suggesting that the condition is probably not Y-linked.  
Likewise, almost 80% of 46,XY women have no mutations in SRY or other Y-linked 
genes (Barbaro et al. 2009; Biason-Lauber et al. 2009; Schimmer & White 2010).  
However, in the remaining 20% of sex reversed women, different missense and 
frameshift mutations in the SRY coding region have been detected (Salehi et al. 2006; 
Shahid et al. 2008; Marchina et al. 2009), thus furthering the need to carry out SRY 
sequence analysis in every individual case of SRY-positive sex reversal. 
Sequencing and sequence analysis of the SRY single exon in the horses involved 
in this study did not reveal any SNPs, mutations, or any other type of sequence 
differences between the cases and the normal male control.  Therefore, the results 
validated the molecular integrity of the SRY on the Y chromosome in the five sex 
reversed horses.  These findings are in agreement with previous studies in horses 
(Switonski et al. 2005; Raudsepp et al. 2010) and humans (Salehi et al. 2006; Shahid et 
al. 2008; Marchina et al. 2009), suggesting that the genetic causes of SRY-positive sex 
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reversal are not necessarily Y-linked and may involve genetic factors located on 
autosomes and the X chromosome. 
 
Autosomal and X-linked Genetic Factors 
 As already reviewed in Introduction, mammalian sex determination involves 
synergistic action of multiple genes, and the genetic causes of abnormal sexual 
development are not necessarily defined by a single gene mutation.  For example, in 
human sex reversed patients, mutations have been found in SF1 (NR5A1) and SOX9 
(Sekido & Lovell-Badge 2008; Domenice et al. 2004) – genes directly interacting with 
SRY.  Additionally, XY sex reversal has been associated with mutations in autosomal 
genes involved in testis determination and gonadal development, such as DMRT1 
(Barbaro et al. 2009), CBX2 (Biason-Lauber et al. 2009), WNT4 (Domenice et al. 2004), 
and two X-linked genes – DAX1 (NR0B1) (Lardone et al. 2011) and AR (Galani et al. 
2008), just to name a few.  Due to mutations in the androgen receptor (AR) gene, the 
human 46,XY sex reversal condition is sometimes referred to as Androgen Insensitivity 
Syndrome (AIS) (Hughes & Deeb 2006).  It has been proposed that testicular 
feminization and male pseudohermaphroditism in SRY-positive mares might also be 
caused by a mutation in the AR (Crabbe et al. 1992; Howden 2004; Switonski et al. 
2005), although, to date, there is no experimental evidence to support this.  Likewise, 
previous sequence analysis of SOX9 on ECA11 and DAX1 on ECAX in our laboratory 
did not reveal any differences between the SRY-positive sex reversed and normal 
animals (unpublished data). 
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 Taken together, the genetic causes of abnormal sexual development, including 
the SRY-positive sex reversal condition can involve one or more genes on autosomes or 
sex chromosomes and shows heterogeneity between individuals and species.  Due to 
this, application of comparative candidate gene approach for the discovery of causative 
mutations underlying the SRY-positive sex reversal syndrome is tedious, time-
consuming, and might not lead to the expected results.  Therefore, in this study, attempts 
were made to study the equine condition using genome-wide approaches. 
 
Single Nucleotide Polymorphism Genotyping 
 Single nucleotide polymorphisms (SNPs) in human and animal genomes are 
widely used and valuable markers to conduct genome-wide association studies of 
Mendelian and complex traits by comparing allele and genotype frequencies across a 
large number of individuals (Shriver et al. 2005; Hoggart et al. 2008).  Therefore, one of 
the most awaited byproducts of the horse genome sequencing project was the discovery 
of over a million SNPs (Wade et al. 2009).  The SNP collection 
(http://www.broadinstitute.org/ftp/distribution/ horse_snp_release/v2/) has been used to 
generate the Equine SNP50 and SNP70 Beadchips, which consist of 54,602 and ~74,000 
highly informative (polymorphic in many breeds) SNPs, respectively, uniformly 
distributed across the equine genome (McCue et al. 2009; Wade et al. 2009).  The 
Equine SNP50 Beadchips have been successfully used for the discovery of single gene 
mutations (Brooks et al. 2010) and candidate regions associated with complex traits, 
such as osteochondrosis (Teyssèdre et al. 2011; Lykkjen et al. 2010) and laryngeal 
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neuropathy (Dupuis et al. 2011).  Importantly, in order to grant sufficient statistical 
power for the analysis, such studies typically use DNA samples from hundreds of 
phenotypically well-defined cases and controls. 
 In the present study with just five cases identified, the use of SNP Beadchip 
genotyping for the detection of likely candidate genomic regions for SRY-positive sex 
reversal was initially not even a consideration.  This was because the phenotypes 
(clinical descriptions) of the five animals were not identical, the animals were not of the 
same breed, and the number of cases was too low for any meaningful statistical analysis.  
However, two sex reversed animals, Standardbreds H348 and H369, had very similar 
phenotypes and were closely related through the maternal lineage (dam of H348 was the 
grand-dam of H369).  Therefore, it was considered worth trying to genotype these two 
animals on the Equine SNP50 Beadchip and analyze the data using genotyping 
information from 46 normal unrelated male Standardbreds (part of an unrelated project 
at the University of Minnesota).  The results of the basic association analysis showing 
two statistically significant SNPs on ECA3 came as a surprise but had to be taken with 
great caution.  It is very likely that the observed deviation of the allele frequencies in the 
two sex reversed animals was solely due to their close relatedness to each other and 
distant relationship to the control Standardbreds.  On the other hand, it cannot be ruled 
out that the two regions on ECA3 are indeed somehow associated with sex reversal.  
Therefore a 16 Mb region demarcated by two SNPs on ECA3 was interrogated in more 
detail using GRAIL (Raychaudhuri et al. 2009) and Ensembl to search for genes 
possibly relevant to sex determination.  Altogether, fifty-two genes were identified that 
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showed various degrees of functional relevance to reproduction and sexual development 
(Table 8) by GRAIL, Ensembl, or GO analyses.  None of these genes, however, have 
been previously associated with sex reversal in humans or other mammalian species.  
The genes that appeared the most number of times in the gene lists belonged to the UGT 
gene family, which encodes for a protein involved in olfactory neuroepithelium.  Genes 
involved in olfactory receptor functional pathways have not been shown to play a role in 
sex reversal.  However olfactory receptors are known to show copy number variation 
between horses (Wade et al. 2009), which is probably the reason why the UGT gene 
family was detected by the SNP analysis.  Indeed, the same gene cluster also showed 
significant copy number variations by array CGH analysis (see below). 
 In the search for candidate genes, a magnesium transporter, NIPA-like domain 
containing 1 (NIPAL1) was selected for sequencing.  The gene was independently 
identified in GRAIL analysis, in manual analysis through Ensembl, and had a GO 
functional gene enrichment score of 1.15.  Although magnesium binds to enzymes and 
nucleic acids and is essential as a signaling molecule (Wu & Veillette 2011), it is not 
clear how magnesium transport is involved in the molecular pathways of sex 
determination.  Also, the sequencing did not reveal significant differences in NIPAL1 
exons between the cases and controls. 
 Nevertheless, the SNP Beadchip analysis, data mining, and candidate gene 
research were useful exercises as well as the first attempt to investigate the genetic 
causes of equine sex reversal using genome-wide approaches.  Despite the limited 
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results, the 16 Mb region on ECA3 and the 52 identified candidate genes set an 
important starting point for future studies. 
 
Copy Number Variation Analysis Using aCGH 
 In addition to SNPs, genomes of individuals within a species can vary by 
submicroscopic insertions, deletions, and segmental duplications ranging from a few 
kilobases (kb) to several megabase pairs (Mb) in size (Redon et al. 2006; Feuk et al. 
2006).  Such copy number variants (CNVs) form a part of normal variation between 
genomes but can also be associated with genome instability, genetic diseases, and 
congenital disorders (Beckmann et al. 2008).  Very recently, CNVs have been associated 
with disorders of sexual development in humans, including the XY sex reversal disorder 
(van Silfhout et al 2009; Tannour-Louet et al. 2010; White et al. 2011), strongly 
encouraging and justifying initiation of array CGH studies for equine sex reversal 
syndrome in this study. 
 Indeed, despite the limited number of cases and the fact that no aCGH data was 
obtained for H252, the most interesting results of this study came from CNV analysis. 
 In general, the number of CNVs detected in the four individuals was proportional 
with the size of the chromosomes, with the exceptions of ECA7, 10, 12, 16, and 20 
where the number of CNVs was higher.  Many of the CNVs detected on ECA7, 12, and 
20 included large regions of olfactory receptor gene clusters, although olfactory receptor 
gene clusters were in CNVs detected on other chromosomes as well.  Olfactory receptor 
genes are widespread throughout the genomes of many species and show high degree of 
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individual variation (Niimura & Nei 2007; Zozulya et al. 2001; Zhang & Firestein 2002; 
Quignon et al. 2005).  Thus, the CNVs containing olfactory receptor genes most likely 
reflect individual differences and are not related to the sex reversal condition.  
Furthermore, the CNVs containing the olfactory receptor gene clusters were present 
sporadically showing no consistent patterns across the individual cases.  As expected, 
the major histocompatibility complex (MHC) on ECA20 was another genomic region 
showing considerable variation between all four cases and the reference genome.  Like 
CNVs in olfactory receptor regions, the CNVs in MHC did not show any common 
pattern between the cases and were considered a part of normal genomic variants.  MHC 
genes play an important role in the immune system and autoimmunity and are known to 
be highly polymorphic across individual horses and equine populations (Brinkemeyer-
Langford et al. 2010). 
 Another important observation from aCGH analysis was that many CNVs 
(>50%) were detected in non-genic regions.  This does not reduce their potential 
functional relevance because duplications or deletions in promoters, enhancers, 
silencers, or other regulatory regions may affect the genes that have a role in sex 
determination.  These results also underlie the need to study equine CNVs using a 
whole-genome tiling array and not restricting the search to coding sequences only. 
 Interestingly, ECA22 and ECAY did not show any CNVs in the four cases.  The 
absence of CNVs on ECAY can be explained by the known low degree of Y sequence 
variation in horses (Wallner et al. 2003; Lindgren et al. 2004) and by the limited number 
(n=512) of ECAY sequences present on the array.  Also, as shown in this and previous 
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studies (Raudsepp et al. 2010), the Y chromosome of SRY-positive XY females has 
retained its integrity and is molecularly the same as in normal males.  In contrast, 
ECA22 is a medium sized (49.9 Mb) chromosome containing 403 protein coding genes, 
thus the lack of CNVs on ECA22 came as a surprise.  This might be because there were 
no structural rearrangements on ECA22 in the four cases, and the chromosome plays no 
role in sex reversal; or this might be because the design of the array with a 7.5 kb 
resolution was not sufficient to detect variations.  Some answers are expected to come 
from our ongoing studies of CNVs in normal individuals representing different horse 
breeds. 
 The primary goal of the aCGH experiments was to identify CNVs that are 
uniquely present in the cases and not in the reference genome, thus attempting to detect 
structural variants that might be associated with the sex reversal condition.  Interestingly, 
there was only one CNV region (CNVR) that was shared between all four cases.  This 
was a region on ECA1 at 158.8-159.1 Mb containing a cluster of genes encoding 
uncharacterized human proteins, and the orthologues have not been described in other 
mammalian species.  Furthermore, the region showed a loss in H169, H348, and H369 
and a gain in H423.  Due to this, the CNVR was not further analyzed in this study but 
might be of interest in future research when annotation of horse genes has improved. 
 The remaining CNVs were present in one, two, or three animals, but not in all 
four.  The highest number of CNVs was found in H348 and the lowest in the Appaloosa, 
H169.  It is possible that this was partially due to technical reasons, although aCGH 
conditions have been thoroughly optimized and both DNA samples and hybridization 
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raw data must pass strict quality control before accepting the data.  Therefore, it is more 
likely that the differences in the numbers and locations of CNVs reflect true individual 
variation.  Not coincidentally, the animal H169 with the lowest number of CNVs also 
had the least severe sex reversal phenotype.  In contrast, the two male hermaphrodite 
Standardbreds, H348 and H369, had the highest numbers of CNVs.  Many of these 
CNVs were shared between the two animals reflecting their close relatedness.  At the 
same time, it was surprising that almost no common CNVs were found between the 
Standardbreds and the Quarter Horse, H423, though all three were described as male 
pseudohermaphrodites.  Instead, H423 shared several CNVs with the Appaloosa, H169, 
suggesting that SRY-positive sex reversal in horses is a genetically heterogeneous 
condition with varying degrees of genetic and phenotypic differences between 
individuals.  Certainly, in order to prove or refute this statement, many more cases from 
the same and different breeds must be investigated. 
 A key for identifying at least some of the genetic causes of this complex 
condition is to investigate phenotypically similar and closely related animals, such as the 
two Standardbreds, H348 and H369, in this study.  The two horses not only had the 
highest numbers of CNVs but also had many in common.  While the majority of shared 
CNVs likely reflect similar genetic structure of the two genomes, a few might pinpoint 
the key regions involved in the abnormal sexual development.  For example, both 
Standardbreds showed a significant gain in the region on ECA1 containing a meiosis-
specific gene, MNS1, and a testis-expressed gene, TEX9.  Notably, this CNV region is 
located just 2 Mb upstream from the only CNVR that was shared among all four cases.  
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Further investigations are needed to determine the connection, if any, of this CNVR to 
male hermaphroditism and sex reversal. 
 The most significant and functionally interesting CNVR in H348 and H369 was a 
massive deletion on ECA29 in a region containing genes belonging to the aldo-keto 
reductase family, including AKR1CL1, AKR1C1, AKR1C2, AKR1C3, and AKR1C4.  
Aldo-keto reductases convert aldehydes and ketones into their corresponding alcohols, 
carry out bile transport, and most relevantly, convert androgens, estrogens, and 
progestins into their less active metabolite form and back into their active form (Jin & 
Penning 2007; Takahashi et al. 2009).  Androgen is a key factor that stimulates and 
controls the development and maintenance of male characteristics.  It is possible that the 
loss of AKR1CL1 and other aldo-keto reductase genes on ECA29 in the two 
Standardbreds has affected sex hormone regulation and might be one of the direct 
genetic causes of the abnormal phenotype.  With so limited information available, it is 
too early to say whether the deletion represents an isolated case in one Standardbred 
family or if it is a common mutation underlying similar phenotypes in other horses.  
Regardless, this is the first report about a likely genetic cause of SRY-positive sex 
reversal in horses.  Furthermore, the deletion was effectively validated both by PCR and 
FISH, providing useful tools for testing suspected XY females for the deletion in future 
studies.  Given that CGH is a costly and elaborate analysis method, such tests will be of 
practical value. 
 Experiments have been initiated to precisely define the ECA29 deletion 
breakpoints so that a simple and reliable PCR test for SRY-positive XY sex reversed 
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mares could be developed.  The currently available PCR primers and amplification 
results have narrowed down the breakpoints to be within 500 bp up- and downstream of 
the deletion start and end sites.  We designed primers, “OUT”, flanking the entire 300 kb 
deletion (Fig. 3) so that the PCR products could be obtained only in animals carrying the 
deletion and not from the normal sequence.  However, no products were obtained in 
cases or controls.  It is possible that due to the resolution of the array in which the 60-
mer oligonucleotides are separated, on average, by 7.5 kb, the deletion start and end 
points were not demarcated precisely, and the primers were designed in the deleted 
sequences.  It is also possible that the primers were designed in regions with incorrect 
sequence assembly.  Nevertheless, demarcation and characterization of deletion 
breakpoints in ECA9 need further experimental work and analyses. 
 Finally, it was of interest to compare the results of aCGH with those of SNP 
genotyping.  Overall, no overlaps between the two datasets were observed.  The regions 
on ECA3, 6, 11, 12, and 28 that showed statistically significant SNPs contained no 
significant CNVs.  This confirms our doubts and caution while interpreting the SNP data 
and supports the idea that the few statistically significant SNPs were detected solely 
because of the close relatedness in H348 and H369.  However, in animal H348, a 
significant gain was found on ECA3 approximately 1 Mb downstream from one of the 
SNPs at 81,332,148-81,380,244 Mb.  The region included a gene in the ATPase gene 
family and a COMM gene, which were also both present when the SNP data was mined 
by GRAIL and Ensembl.  This proves that there is a structural variation at that position 
on ECA3 in H348.  Additional experiments are needed to validate this CNV by qPCR.  
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Also, functional relevance of ATPase and COMM-domain genes to sexual development 
needs to be ascertained. 
 This is the first time aCGH has been used to investigate genetic causes of equine 
congenital disorders.  Though the results are preliminary, need further validation by PCR 
and FISH, and require comparison with CNVs in normal horse populations, the findings 
clearly show the involvement of structural rearrangements in disorders of sexual 
development in horses.  Additionally, the experiments carried out in this study validate 
the utility of the equine whole-genome tiling array for the study of variation in the horse 
genome in health and disease. 
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CONCLUSIONS 
 
• The five horses involved in this study were genetically males having a 64,XY 
karyotype but phenotypically females or female-like; 
• The Y chromosome of all studied animals carried the SRY gene, and the sequence 
was the same as in normal male horses; 
• A ~300 kb deletion in aldo-keto reductase gene family on ECA29 was found to 
be a likely cause of the sex reversal condition in two out of the five studied 
animals; 
• The SRY-positive male-to female sex reversal condition in horses is a genetically 
heterogeneous condition. 
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